피듀셜 마커 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 제품별, 모달리티별, 암종별, 최종사용자별, 지역별, 경쟁별(2020-2030년)
Fiducial Markers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Modality, By Cancer Type, By End User, By Region and Competition, 2020-2030F
상품코드:1881485
리서치사:TechSci Research
발행일:2025년 11월
페이지 정보:영문 187 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 피듀셜 마커 시장은 2024년에 9,738만 달러로 평가되었으며, 2030년까지 CAGR 5.3%로 성장하여 1억 3,275만 달러에 달할 것으로 예측됩니다.
피듀셜 마커는 의료 영상 진단에서 방사선 치료나 수술의 가이드가 되는 정밀한 기준점을 설정하기 위해 사용되는 작은 크기의 내장형 물체입니다. 이를 통해 종양의 위치를 정확하게 파악하고 건강한 조직에 대한 부수적인 손상을 최소화할 수 있습니다. 이러한 마커 세계 시장은 주로 전 세계 암 발생률 증가, MRI 및 CBCT와 같은 첨단 영상 진단 방법의 보급 확대, 정밀 방사선 치료 기술의 지속적인 발전에 의해 주도되고 있습니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
9,738만 달러
시장 규모 : 2030년
1억 3,275만 달러
CAGR : 2025-2030년
5.3%
가장 빠르게 성장하는 부문
금속 기반 마커
최대 시장
북미
주요 시장 촉진요인
전 세계적으로 암 발생률이 증가함에 따라 정밀한 방사선 치료를 필요로 하는 환자 수가 증가하면서 피듀셜 마커에 대한 수요가 크게 증가하고 있습니다. 암 유병률이 증가함에 따라, 특히 민감한 해부학적 부위에서 정확한 종양 위치 파악이 필수적으로 요구되고 있습니다.
주요 시장 과제
피듀셜 마커 삽입 시술에 따른 막대한 비용은 세계 피듀셜 마커 시장 성장에 큰 장벽으로 작용하고 있습니다. 마커 본체, 수술 전문 기술, 전용 장비, 정확한 배치를 위해 필요한 추적 영상 진단 등 이러한 비용이 보급을 제한하고 있습니다.
주요 시장 동향
생분해성 마커의 개발은 환자의 편의성 향상과 이차적 제거 시술의 필요성 감소를 실현하여 환자의 치료 결과를 향상시키고 의료비를 절감할 수 있는 잠재력을 가지고 있습니다. 이러한 혁신은 지속가능하고 환자 친화적인 솔루션으로 의료 분야 전체가 전환하는 추세에 부합하는 것입니다.
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 소리
제5장 세계의 피듀셜 마커 시장 전망
시장 규모 및 예측
금액별
시장 점유율과 예측
제품별(금속 기반 마커, 폴리머 기반 마커, 기타 피듀셜 마커)
모달리티별(CT/CBCT, MRI, 초음파, 방사선 치료)
암종별(전립선암, 폐암, 유방암, 위암, 기타 암)
최종사용자별(병원·진료소, 독립 방사선 치료 센터, 암 연구 센터)
지역별
기업별(2024)
시장 맵
제6장 북미의 피듀셜 마커 시장 전망
시장 규모 및 예측
시장 점유율과 예측
북미 : 국가별 분석
미국
캐나다
멕시코
제7장 유럽의 피듀셜 마커 시장 전망
시장 규모 및 예측
시장 점유율과 예측
유럽 : 국가별 분석
독일
프랑스
영국
이탈리아
스페인
제8장 아시아태평양의 피듀셜 마커 시장 전망
시장 규모 및 예측
시장 점유율과 예측
아시아태평양 : 국가별 분석
중국
인도
일본
한국
호주
제9장 중동 및 아프리카의 피듀셜 마커 시장 전망
시장 규모 및 예측
시장 점유율과 예측
중동 및 아프리카 : 국가별 분석
사우디아라비아
아랍에미리트
남아프리카공화국
제10장 남미의 피듀셜 마커 시장 전망
시장 규모 및 예측
시장 점유율과 예측
남미 : 국가별 분석
브라질
콜롬비아
아르헨티나
제11장 시장 역학
성장 촉진요인
과제
제12장 시장 동향과 발전
인수합병
제품 출시
최근 동향
제13장 세계의 피듀셜 마커 시장 : SWOT 분석
제14장 Porter's Five Forces 분석
업계내 경쟁
신규 참여의 가능성
공급업체의 능력
고객의 능력
대체품의 위협
제15장 경쟁 구도
CIVCO Radiotherapy
IZI Medical Products
Boston Scientific Corporation
Naslund Medical AB
Best Medical International, Inc.
Nanovi A/S
Carbon Medical Technologies Inc.
Eckert & Ziegler
Innovative Oncology Solutions
Medtronic plc
제16장 전략적 제안
제17장 조사 회사 소개 및 면책사항
KSM
영문 목차
영문목차
The Global Fiducial Markers Market, valued at USD 97.38 Million in 2024, is projected to experience a CAGR of 5.3% to reach USD 132.75 Million by 2030. Fiducial markers are small, implantable objects utilized in medical imaging to establish precise reference points for guiding radiation therapy and surgical procedures, thereby enabling accurate tumor localization and minimizing collateral damage to healthy tissue. The global market for these markers is primarily propelled by the increasing worldwide incidence of cancer, the expanding adoption of advanced imaging modalities like MRI and CBCT, and continuous technological advancements in precision radiotherapy techniques.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 97.38 Million
Market Size 2030
USD 132.75 Million
CAGR 2025-2030
5.3%
Fastest Growing Segment
Metal Based Markers
Largest Market
North America
Key Market Drivers
The rising global incidence of cancer significantly propels demand for fiducial markers by expanding the patient population requiring precise radiation therapy. Growing cancer prevalence necessitates accurate tumor localization, particularly in sensitive anatomical regions. Fiducial markers are essential for precision in modern oncology, enhancing therapeutic efficacy and minimizing collateral damage. According to the American Cancer Society, in April 2024, lung cancer was the most frequently diagnosed cancer in 2022, with approximately 2.5 million new cases globally, highlighting a substantial disease burden often necessitating targeted radiation treatment. This prevalence drives continuous demand for accurate therapeutic guidance.
Key Market Challenges
The significant cost associated with fiducial marker implantation procedures presents a considerable impediment to the growth of the Global Fiducial Markers Market. These expenses, encompassing the markers, surgical expertise, specialized equipment, and necessary follow-up imaging for precise placement, restrict widespread adoption. This high expenditure is particularly challenging within healthcare systems facing budget constraints or limited reimbursement policies, directly impacting market penetration and resulting in lower utilization rates despite the acknowledged benefits of improved treatment accuracy and reduced collateral damage.
Key Market Trends
Biodegradable marker development addresses patient comfort and reduces the need for secondary removal procedures, thereby enhancing patient outcomes and potentially reducing healthcare costs. This innovation aligns with the broader medical shift toward sustainable and patient-friendly solutions. The American Medical Association, at its 2023 Interim Meeting, referred Resolution 2-I-23 concerning single-use/disposable medical devices, acknowledging the need to address adverse environmental consequences and balance fiscal expense with patient safety concerns, which reflects the growing recognition of biodegradable material benefits.
Key Market Players
CIVCO Radiotherapy
IZI Medical Products
Boston Scientific Corporation
Naslund Medical AB
Best Medical International, Inc.
Nanovi A/S
Carbon Medical Technologies Inc.
Eckert & Ziegler
Innovative Oncology Solutions
Medtronic plc
Report Scope:
In this report, the Global Fiducial Markers Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Fiducial Markers Market, By Product:
Metal-based Markers
Polymer-based Markers
Other Fiducial Markers
Fiducial Markers Market, By Modality:
CT/CBCT
MRI
Ultrasound
Radiotherapy
Fiducial Markers Market, By Cancer Type:
Prostate Cancer
Lung Cancer
Breast Cancer
Gastric Cancer
Other Cancers
Fiducial Markers Market, By End user:
Hospitals & Clinics
Independent Radiotherapy Centers
Cancer Research Centers
Fiducial Markers Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global Fiducial Markers Market.
Available Customizations:
Global Fiducial Markers Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Fiducial Markers Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (Metal-based Markers, Polymer-based Markers, Other Fiducial Markers)
5.2.2. By Modality (CT/CBCT, MRI, Ultrasound, Radiotherapy)
5.2.3. By Cancer Type (Prostate Cancer, Lung Cancer, Breast Cancer, Gastric Cancer, Other Cancers)
5.2.4. By End user (Hospitals & Clinics, Independent Radiotherapy Centers, Cancer Research Centers)
5.2.5. By Region
5.2.6. By Company (2024)
5.3. Market Map
6. North America Fiducial Markers Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product
6.2.2. By Modality
6.2.3. By Cancer Type
6.2.4. By End user
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Fiducial Markers Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product
6.3.1.2.2. By Modality
6.3.1.2.3. By Cancer Type
6.3.1.2.4. By End user
6.3.2. Canada Fiducial Markers Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product
6.3.2.2.2. By Modality
6.3.2.2.3. By Cancer Type
6.3.2.2.4. By End user
6.3.3. Mexico Fiducial Markers Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product
6.3.3.2.2. By Modality
6.3.3.2.3. By Cancer Type
6.3.3.2.4. By End user
7. Europe Fiducial Markers Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Modality
7.2.3. By Cancer Type
7.2.4. By End user
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Fiducial Markers Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Modality
7.3.1.2.3. By Cancer Type
7.3.1.2.4. By End user
7.3.2. France Fiducial Markers Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Modality
7.3.2.2.3. By Cancer Type
7.3.2.2.4. By End user
7.3.3. United Kingdom Fiducial Markers Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Modality
7.3.3.2.3. By Cancer Type
7.3.3.2.4. By End user
7.3.4. Italy Fiducial Markers Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product
7.3.4.2.2. By Modality
7.3.4.2.3. By Cancer Type
7.3.4.2.4. By End user
7.3.5. Spain Fiducial Markers Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product
7.3.5.2.2. By Modality
7.3.5.2.3. By Cancer Type
7.3.5.2.4. By End user
8. Asia Pacific Fiducial Markers Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Modality
8.2.3. By Cancer Type
8.2.4. By End user
8.2.5. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Fiducial Markers Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Modality
8.3.1.2.3. By Cancer Type
8.3.1.2.4. By End user
8.3.2. India Fiducial Markers Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Modality
8.3.2.2.3. By Cancer Type
8.3.2.2.4. By End user
8.3.3. Japan Fiducial Markers Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Modality
8.3.3.2.3. By Cancer Type
8.3.3.2.4. By End user
8.3.4. South Korea Fiducial Markers Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Modality
8.3.4.2.3. By Cancer Type
8.3.4.2.4. By End user
8.3.5. Australia Fiducial Markers Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Modality
8.3.5.2.3. By Cancer Type
8.3.5.2.4. By End user
9. Middle East & Africa Fiducial Markers Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Modality
9.2.3. By Cancer Type
9.2.4. By End user
9.2.5. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Fiducial Markers Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Modality
9.3.1.2.3. By Cancer Type
9.3.1.2.4. By End user
9.3.2. UAE Fiducial Markers Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Modality
9.3.2.2.3. By Cancer Type
9.3.2.2.4. By End user
9.3.3. South Africa Fiducial Markers Market Outlook
